Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe...Further, Moderna confirmed it's in discussions with the U.S. government to move forward with...
Vaxart Provides Business Update
Morningstar· 5 days agoVaxart is developing the most advanced oral pill vaccine platform that provides a more convenient formulation compared to injectable vaccines, generates ...
Gateway - Quartz
Quartz· 4 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical & ...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 5 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
New Human Cases of Avian Flu Anticipated
Medscape· 4 days agoWith avian influenza spreading quickly around the globe, the virus has more opportunities to mutate and cause problems for people. By some calculations,...
Sinovac denounces alleged US discredit campaign, warns of vaccine hesitancy risks
China Daily· 6 days agoChinese vaccine maker Sinovac Biotech said on Sunday that stigmatizing vaccines could contribute to vaccine hesitancy, undermine trust ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 5 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 3 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
The First Three Months
The Atlantic· 6 days agoA reporter calling me at home on a holiday about a possible disease outbreak was concerning, but not that unusual. The press sometimes had better, or at...
Vaxart Stock Is Moving Higher After The Bell: What's Going On? - Vaxart (NASDAQ:VXRT)
Benzinga· 5 days agoVaxart Inc VXRT shares are trading higher in Monday’s after-hours session after the company provided...
